1,3,7-trimethyl-1H-purine-2,6(3H,7H)-dione

01

02

03

04

05

Hebei Guangxiang Pharmaceutical

China

AIChE Annual Meeting

Not Confirmed

06

Siegfried AG

Switzerland

AIChE Annual Meeting

Not Confirmed

Looking for 58-08-2 / Caffeine API manufacturers, exporters & distributors?

PharmaCompass offers a list of Caffeine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Caffeine manufacturer or Caffeine supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Caffeine manufacturer or Caffeine supplier.

PharmaCompass also assists you with knowing the Caffeine API Price utilized in the formulation of products. Caffeine API Price is not always fixed or binding as the Caffeine Price is obtained through a variety of data sources. The Caffeine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Caffeine

Synonyms

58-08-2, Guaranine, 1,3,7-trimethylxanthine, Methyltheobromine, Theine, Thein

Cas Number

58-08-2

Unique Ingredient Identifier (UNII)

3G6A5W338E

About Caffeine

A methylxanthine naturally occurring in some beverages and also used as a pharmacological agent. Caffeine's most notable pharmacological effect is as a central nervous system stimulant, increasing alertness and producing agitation. It also relaxes SMOOTH MUSCLE, stimulates CARDIAC MUSCLE, stimulates DIURESIS, and appears to be useful in the treatment of some types of headache. Several cellular actions of caffeine have been observed, but it is not entirely clear how each contributes to its pharmacological profile. Among the most important are inhibition of cyclic nucleotide PHOSPHODIESTERASES, antagonism of ADENOSINE RECEPTORS, and modulation of intracellular calcium handling.

1,3,7-trimethyl-1H-purine-2,6(3H,7H)-dione Manufacturers

A 1,3,7-trimethyl-1H-purine-2,6(3H,7H)-dione manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 1,3,7-trimethyl-1H-purine-2,6(3H,7H)-dione, including repackagers and relabelers. The FDA regulates 1,3,7-trimethyl-1H-purine-2,6(3H,7H)-dione manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 1,3,7-trimethyl-1H-purine-2,6(3H,7H)-dione API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of 1,3,7-trimethyl-1H-purine-2,6(3H,7H)-dione manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

1,3,7-trimethyl-1H-purine-2,6(3H,7H)-dione Suppliers

A 1,3,7-trimethyl-1H-purine-2,6(3H,7H)-dione supplier is an individual or a company that provides 1,3,7-trimethyl-1H-purine-2,6(3H,7H)-dione active pharmaceutical ingredient (API) or 1,3,7-trimethyl-1H-purine-2,6(3H,7H)-dione finished formulations upon request. The 1,3,7-trimethyl-1H-purine-2,6(3H,7H)-dione suppliers may include 1,3,7-trimethyl-1H-purine-2,6(3H,7H)-dione API manufacturers, exporters, distributors and traders.

click here to find a list of 1,3,7-trimethyl-1H-purine-2,6(3H,7H)-dione suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

1,3,7-trimethyl-1H-purine-2,6(3H,7H)-dione KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a 1,3,7-trimethyl-1H-purine-2,6(3H,7H)-dione Drug Master File in Korea (1,3,7-trimethyl-1H-purine-2,6(3H,7H)-dione KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of 1,3,7-trimethyl-1H-purine-2,6(3H,7H)-dione. The MFDS reviews the 1,3,7-trimethyl-1H-purine-2,6(3H,7H)-dione KDMF as part of the drug registration process and uses the information provided in the 1,3,7-trimethyl-1H-purine-2,6(3H,7H)-dione KDMF to evaluate the safety and efficacy of the drug.

After submitting a 1,3,7-trimethyl-1H-purine-2,6(3H,7H)-dione KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their 1,3,7-trimethyl-1H-purine-2,6(3H,7H)-dione API can apply through the Korea Drug Master File (KDMF).

click here to find a list of 1,3,7-trimethyl-1H-purine-2,6(3H,7H)-dione suppliers with KDMF on PharmaCompass.

1,3,7-trimethyl-1H-purine-2,6(3H,7H)-dione Manufacturers | Traders | Suppliers

We have 3 companies offering 1,3,7-trimethyl-1H-purine-2,6(3H,7H)-dione

Get in contact with the supplier of your choice:

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.

1,3,7-trimethyl-1H-purine-2,6(3H,7H)-dione

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

67 API Suppliers

10 USDMF

10 CEP/COS

11 JDMF

1 EU WC

6 KDMF

18 NDC API

31 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

64 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

486 FDF Dossiers

126 FDA Orange Book

104 Europe

38 Canada

129 South Africa

89 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 356.4MG;30MG;16MG

TABLET;ORAL - 325MG;50MG;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - 325MG;50MG;40MG;30MG

CAPSULE;ORAL - 325MG;50MG;40MG;30MG

TABLET;ORAL - 250MG;250MG;65MG

TABLET;ORAL - 100MG;1MG

TABLET;ORAL - 325MG;50MG;40MG

SUPPOSITORY;RECTAL - 100MG;2MG

TABLET;ORAL - 325MG;50MG;40MG

RELATED EXCIPIENT COMPANIES

2 EUROAPI

1 Minakem

1 Evonik

13 Rochem International Inc

31 SPI Pharma

31 DKSH

2 Pharm-RX Chemical

9 Boai NKY Pharmaceuticals Ltd

9 Gangwal Healthcare

1 ICE Pharma

16 Nanjing Well Pharmaceutical

1 Shanghai Minbiotech

2 Pfanstiehl

1 Capital Farma

13 Kirsch Pharma

4 ACG Worldwide

21 Actylis

2 Aeon Procare

1 Alcedo Pharmachem

10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

4 Ashland

46 BASF

1 Bioplus Life Sciences

3 CD Formulation

4 Clariant

13 Corel Pharma Chem

7 DFE Pharma

2 Esteem Industries

3 Finar

15 Gangwal Chemicals

1 Hayashibara

5 Ideal Cures

5 Ingredion Pharma Solutions

26 Kerry

4 Keval Exports

5 Kima Chemical

6 Lonza Capsugel

2 Lubrizol Life Science Health

26 Microlex e.U

1 Nanjing Bold Chemical

2 Nippon Fine Chemical

2 Nitika Pharmaceutical Specialities

TABLET;ORAL - 325MG;50MG;40MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons